ArticleFrontiers in pharmacology2024

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States.

Wentao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.